Literature DB >> 9520487

Profound neuronal plasticity in response to inactivation of the dopamine transporter.

S R Jones1, R R Gainetdinov, M Jaber, B Giros, R M Wightman, M G Caron.   

Abstract

The dopamine transporter (DAT) plays an important role in calibrating the duration and intensity of dopamine neurotransmission in the central nervous system. We have used a strain of mice in which the gene for the DAT has been genetically deleted to identify the DAT's homeostatic role. We find that removal of the DAT dramatically prolongs the lifetime (300 times) of extracellular dopamine. Within the time frame of neurotransmission, no other processes besides diffusion can compensate for the lack of the DAT, and the absence of the DAT produces extensive adaptive changes to control dopamine neurotransmission. Despite the absence of a clearance mechanism, dopamine extracellular levels were only 5 times greater than control animals due to a 95% reduction in content and a 75% reduction in release. Paradoxically, dopamine synthesis rates are doubled despite a decrease of 90% in the levels of tyrosine hydroxylase and degradation is markedly enhanced. Thus, the DAT not only controls the duration of extracellular dopamine signals but also plays a critical role in regulating presynaptic dopamine homeostasis. It is interesting to consider that the switch to a dopamine-deficient, but functionally hyperactive, mode of neurotransmission observed in mice lacking the DAT may represent an extreme example of neuronal plasticity resulting from long-term psychostimulant abuse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520487      PMCID: PMC19957          DOI: 10.1073/pnas.95.7.4029

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Regulation of recombinant rat tyrosine hydroxylase by dopamine.

Authors:  P Ribeiro; Y Wang; B A Citron; S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

Review 3.  Principles of voltammetry and microelectrode surface states.

Authors:  K T Kawagoe; J B Zimmerman; R M Wightman
Journal:  J Neurosci Methods       Date:  1993-07       Impact factor: 2.390

4.  5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum.

Authors:  P M Groves; J C Linder; S J Young
Journal:  Neuroscience       Date:  1994-02       Impact factor: 3.590

5.  Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain.

Authors:  P A Garris; E L Ciolkowski; P Pastore; R M Wightman
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

Review 6.  Neurotransmitter transporters: recent progress.

Authors:  S G Amara; M J Kuhar
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

Review 7.  Quantitative microdialysis of neurotransmitters.

Authors:  J B Justice
Journal:  J Neurosci Methods       Date:  1993-07       Impact factor: 2.390

8.  Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.

Authors:  S Kaakkola; R J Wurtman
Journal:  Brain Res       Date:  1992-08-07       Impact factor: 3.252

Review 9.  Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology.

Authors:  L F Agnati; B Bjelke; K Fuxe
Journal:  Med Res Rev       Date:  1995-01       Impact factor: 12.944

10.  Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study.

Authors:  P A Garris; R M Wightman
Journal:  J Neurosci       Date:  1994-01       Impact factor: 6.167

View more
  210 in total

1.  Amino acid transport system A resembles system N in sequence but differs in mechanism.

Authors:  R J Reimer; F A Chaudhry; A T Gray; R H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.

Authors:  M Syringas; F Janin; B Giros; J Costentin; J J Bonnet
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 3.  The behavioral activation system and mania.

Authors:  Sheri L Johnson; Michael D Edge; M Kathleen Holmes; Charles S Carver
Journal:  Annu Rev Clin Psychol       Date:  2011-11-07       Impact factor: 18.561

4.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

5.  Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine.

Authors:  Paul E M Phillips; Josephine M Johns; Deborah A Lubin; Evgeny A Budygin; Raul R Gainetdinov; Jeffery A Lieberman; R Mark Wightman
Journal:  Brain Res       Date:  2003-01-24       Impact factor: 3.252

6.  Presynaptic dopamine dynamics in striatal brain slices with fast-scan cyclic voltammetry.

Authors:  Francis K Maina; Madiha Khalid; Aaron K Apawu; Tiffany A Mathews
Journal:  J Vis Exp       Date:  2012-01-12       Impact factor: 1.355

7.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

8.  Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice.

Authors:  Morgane Thomsen; F Scott Hall; George R Uhl; S Barak Caine
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

10.  Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

Authors:  Freja Herborg; Thorvald F Andreassen; Frida Berlin; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.